Extensive Actinic Keratosis Now More Treatable with Tirbanibulin 1%
A New Hope for Extensive Actinic Keratosis Patients
Actinic keratosis (AK) is a common skin condition caused by prolonged sun exposure. It typically appears as rough, scaly patches on sun-exposed areas of the skin, such as the face, scalp, hands, and forearms. While AK is usually benign, it can sometimes develop into skin cancer if left untreated.
Extensive AK, which affects a large area of the skin, can be particularly difficult to treat. Traditional treatments, such as cryotherapy and topical 5-fluorouracil, can be painful and cause significant skin irritation.
However, a new treatment option has recently emerged that offers hope for people with extensive AK: tirbanibulin 1%.
Introducing Tirbanibulin 1%
Tirbanibulin 1% is a topical gel that is applied once daily for 5 days. It works by inhibiting the growth of abnormal skin cells, thereby reducing the severity and number of AK lesions.
Clinical Trials Show Promise
Clinical trials have shown that tirbanibulin 1% is safe and effective for treating extensive AK. In one study, over 70% of patients experienced a 75% or greater reduction in the number of AK lesions after 12 weeks of treatment.
Fewer Side Effects than Traditional Treatments
Tirbanibulin 1% is generally well-tolerated, with the most common side effects being mild skin irritation and redness. These side effects are typically temporary and resolve within a few days of stopping treatment.
Conclusion
Tirbanibulin 1% is a safe and effective treatment option for extensive AK. It offers a convenient and well-tolerated alternative to traditional treatments, with a high success rate and minimal side effects. If you have extensive AK, talk to your doctor about whether tirbanibulin 1% is right for you.
Kind regards F. Hillsom.
